Bioasis Technologies (FRA:107) Institutional Ownership : 0.08% (As of Jun. 19, 2024)

View and export this data going back to 2017. Start your Free Trial

What is Bioasis Technologies Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Bioasis Technologies's institutional ownership is 0.08%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Bioasis Technologies's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Bioasis Technologies's Float Percentage Of Total Shares Outstanding is 0.00%.

Bioasis Technologies Institutional Ownership Historical Data

The historical data trend for Bioasis Technologies's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioasis Technologies Institutional Ownership Chart

Bioasis Technologies Historical Data

The historical data trend for Bioasis Technologies can be seen below:

	2016-01-31	2016-02-29	2016-03-31	2016-04-30	2016-05-31	2016-06-30	2016-07-31	2016-08-31	2016-09-30	2016-10-31
Institutional Ownership	0.09	0.08	0.08	0.08	0.08	0.08	0.08	0.08	0.08	0.08

Bioasis Technologies Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

Bioasis Technologies (FRA:107) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bioasis Technologies Inc (FRA:107) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

N/A

Address

157 Church Street, 19th Floor, New Haven, CT, USA, 06510

Website

https://www.bioasis.us

Bioasis Technologies Inc is a development stage biopharmaceutical company. It is engaged in the research and development of products for the diagnosis and treatment of neurological diseases and disorders. The company has worked on a blood-brain barrier program and studies disorders in the brain. The company's xB3 program describes its proprietary carrier, for the delivery of therapeutics across the blood-brain barrier and the treatment of CNS disorders in areas of high unmet medical need, including brain cancers and neurodegenerative diseases. The company's in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.

Bioasis Technologies (FRA:107) Headlines

No Headlines